CSF3 and chronic graft versus host disease: In the univariate analysis, the cumulative incidence of overall chronic GVHD was significantly higher in patients receiving G‐CSF compared to those not receiving it following BMT (p = .007) and CBT (p = .005), but not PBSCT (p = .260) (Figure 1D–F).